Home > PS Ratio > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 2.83.

Share Price ₹962.6Mar 11,2025
Market Cap ₹423.5 Cr
Sales-TTM₹149.5 CrTTM-Standalone Results
Price/Sales2.83xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JENBURKT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹423.5 Cr] as on Mar 11,2025

(/) Sales [ ₹149.5 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 2.83x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '2.83 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS


PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS

- JENBURKT PHARMACEUTICALS 's latest p/e ratio is 2.83x.

- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.86x.

- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.1x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 2.15x.

- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 1.23x.


How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JENBURKT PHARMACEUTICALS 149.52.83423.5
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.70397,246.0
DIVIS LABORATORIES LTD9,078.016.21147,119.0
CIPLA LTD26,981.24.33116,805.0
TORRENT PHARMACEUTICALS LTD11,302.09.16103,554.0
DR REDDYS LABORATORIES LTD31,229.32.9893,192.0
MANKIND PHARMA LTD11,641.07.8391,196.4
ZYDUS LIFESCIENCES LTD22,247.44.0790,551.0
LUPIN LTD22,001.64.1090,226.2
AUROBINDO PHARMA LTD30,921.82.0563,368.4
ABBOTT INDIA LTD6,243.210.3864,826.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.05x
Max industry PS 16.21x
Median industry PS 4.33x
Average industry PS 6.51x



You may also like the below Video Courses